Compensatory reactions during impairment of granulocytic stem in patients with lung cancer receiving antitumor chemotherapy.

V E Gol'dberg V V Zhdanov M G Matyash E I Simolina T Y Khrichkova V V Vysotskaya N O Popova D A Boldyshev

Bull Exp Biol Med

Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.

Published: June 2001

We compared changes in the granulocytic hemopoietic stem in patients with stage III-IV lung cancer receiving cytostatic therapy by the original CVC and standard CAM schemes. In patients treated with the CVC regimen, the granulocytic hemopoietic stem possessed more potent compensatory capacities.

Download full-text PDF	Source
http://dx.doi.org/10.1023/a:1012358704040	DOI Listing

Publication Analysis

Top Keywords

stem patients

lung cancer

cancer receiving

granulocytic hemopoietic

hemopoietic stem

compensatory reactions

reactions impairment

impairment granulocytic

granulocytic stem

patients lung

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!